Skip to contentE
Eledon Pharmaceuticals, Inc.
E
ELDNEledon Pharmaceuticals, Inc. Released Nov 10, 2014, after the close
10-Q filed Nov 13, 2014, 44 days after period end · 0001193125-14-411225
Q3 2014 · 10-Q
Revenue$0.00$0.00— vs Q3 2013no prior Q2 2014 on file Net Income-$6.39M-$6.39M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
N/M vs Q2 2014
EPS Diluted-$2.71-$2.71N/M vs Q3 2013N/M vs Q2 2014 Operating Income-$6,424,000N/M Operating Cash Flowderived-$4,464,000— Free Cash Flowderived-$4,471,000— ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end